Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
medical device
national blog main
20/20 healthcare partners
alder biopharmaceutical
allergan
american academy of neurology
amgen
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
atogepant
biohaven
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
christian angermayer
clinical trials
detroit blog main
detroit top stories
dolby family ventures
drugs
eli lilly
enclear therapies
eptinezumab
erenumab
fda
financing
fremanezumab
funding
galcanezumab
gf securities
global health sciences fund
What
companies
2
×
drugs
neuro
2
×
new
therapies
approval
arguments
associated
big
class
commercialized
competitors
decades
develop
device
dialysis
disease
diseases
drug
enclear
fda
harmful
make
meeting
migraine
nets
neurodegenerative
oral
potential
proteins
raised
target
test
won
working
year
Language
unset
Current search:
neuro
×
companies
×
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
